Market Opportunity Target expansion in mental health telemedicine by highlighting KetaMD's at‑home ketamine treatment model, HIPAA compliance, and Florida launch history to approach other states with high demand and regulatory readiness.

Strategic Partnerships Leverage affiliations with Braxia Scientific and existing telemedicine platforms to pitch co‑branding, white‑label options, or referral collaborations that accelerate user acquisition and credibility in new markets.

Growth Levers Position competitive pricing and scalable nurse‑guided care as differentiators to win early adopters and clinics seeking affordable, compliant at‑home treatment solutions, while addressing the S.A.A.D. epidemic.

Sales Milestones Emphasize proven platform availability in Florida and international potential post‑acquisition history to engage investors or clients looking for a tested telemedicine ketamine solution with a clear regulatory path.

Operational Readiness Highlight HIPAA compliance, secure platform, and a lean team as a strength for onboarding partnerships quickly, while outlining customer success and clinician support workflows to reduce time‑to‑value for customers.